SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zim Laboratories informs about EGM

19 Nov 2022 Evaluate

In continuation to the outcome of the Board Meeting dt.12th November, 2022 and pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Zim Laboratories has informed that it enclosed the notice of the EGM scheduled to be held on 12th December, 2022 through Video Conferencing (VC) / Other Audio-Visual Means (OAVM) seeking the consent of the shareholders on the matters set out in the notice. The notice of EGM is also available on Company’s website at www.zimlab.in. The cut-off date for remote e-voting is Monday, 05th December, 2022. The remote e-voting shall commence on Friday, 09th December, 2022 at 09:00 am and ends on Sunday, 11th December, 2022 at 05:00 pm.

The above information is a part of company’s filings submitted to BSE.

Zim Laboratories Share Price

79.72 3.72 (4.89%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×